Jul 31, 2015 02:00PM
Jul 31, 2015 01:22PM
Jul 27, 2015 09:58AM
Jul 27, 2015 06:07AM
Jul 27, 2015 06:03AM
Jul 27, 2015 04:31AM
Jul 27, 2015 04:30AM Teva to Acquire Allergan Generics for $40.5 Billion Creating a Transformative Generics and Specialty Company Well Positioned to Win in Global Healthcare
Jul 23, 2015 09:06AM
Jul 23, 2015 09:02AM
Jun 19, 2015 08:35AM
Jun 19, 2015 08:30AM
May 8, 2015 12:40PM
May 5, 2015 08:32AM
May 5, 2015 08:30AM Teva Provides Additional Detail on Proposed Acquisition of Mylan
Apr 29, 2015 04:13PM
Apr 27, 2015 10:38AM
Apr 27, 2015 10:37AM
Apr 22, 2015 08:33AM
Apr 22, 2015 08:30AM
Apr 21, 2015 10:01AM
Apr 21, 2015 08:46AM Teva Pharma (TEVA) Offers $82/Share for Mylan (MYL)
Apr 21, 2015 08:45AM
Apr 7, 2015 02:52PM
Apr 7, 2015 07:29AM
Mar 30, 2015 09:31AM
Mar 5, 2015 09:01AM
Mar 19, 2014 10:56AM
Mar 7, 2014 06:53AM Barclays Upgrades Teva Pharma (TEVA) to Overweight
Nov 4, 2013 10:44AM
Aug 5, 2013 09:40AM
Jul 30, 2013 09:37AM
Dec 12, 2012 03:28PM
Jun 19, 2012 03:48PM
May 25, 2012 01:21PM
May 11, 2012 01:26PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium
Apr 9, 2012 02:10PM
Mar 15, 2012 10:43AM
Feb 15, 2012 02:08PM
Feb 15, 2012 11:23AM
Dec 9, 2011 01:15PM
Nov 8, 2011 11:05AM
Nov 3, 2011 11:15AM Notable Analyst Rating Changes 11/03: (TEVA) (ARO) (OPEN) Upgraded; (DNDN) (DXCM) (NLY) Downgraded
Oct 24, 2011 10:47AM
May 16, 2011 02:05PM
May 12, 2011 02:19PM
May 9, 2011 11:02AM
Apr 21, 2011 02:21PM
Apr 19, 2011 10:44AM
Apr 12, 2011 02:21PM Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); Detailed Laquinimod Results Support Our Positive View
Mar 25, 2011 01:29PM

30,239 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All